USPTO serial 90756656
PROPHASE PRECISION MEDICINE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SAUNDERS, ANDREA DAWN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PROPHASE PRECISION MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Darren B. Cohen
Darren B. Cohen REED SMITH LLP599 LEXINGTON AVENUENEW YORK, NY 10022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Kits comprising primarily of regents, enzymes and nucleotides for genetic research and genome sequencing for use in medical, scientific and genealogical and family history research; reagents, enzymes, and nucleotides for scientific or medical research use; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or medical research purposes; reagents for scientific or medical use, namely, reagents for use in preparation of DNA sequencing samples; clinical diagnostic reagents for medical or laboratory use | ACTIVE | — |
| 005 | Medical diagnostic reagents; diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing; medical diagnostic assays for the detection of infectious and viral diseases; medical diagnostic reagents and assays for testing body fluids; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes | ACTIVE | — |
| 010 | Diagnostic test kits for use in genome sequencing comprised of medical and diagnostic devices for collecting DNA samples, all for genetic research and genome sequencing for use in medical, scientific and genealogical and family history research; Medical diagnostic apparatus and instruments for detecting genetic sequence and related genome sequencing purposes | ACTIVE | — |
| 042 | Genome sequencing testing for scientific research purposes to enable the prevention, diagnosis, and treatment of genetic diseases | ACTIVE | — |
| 044 | Genome sequencing testing for medical purposes to enable the prevention, diagnosis and treatment genetic diseases; full line of medical diagnostic testing, including but not limited to blood, urine, toxicology and pathology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ProPhase Labs, Inc.
- Other trademarks owned by ProPhase Labs, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PROPHASE PRECISION MEDICINE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 8, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 2, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 2, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 31, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 31, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 30, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 30, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 30, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 31, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 31, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 8, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 6, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 6, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 6, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 1, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 1, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 1, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 1, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 28, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 9, 2021 | NWAP | NEW APPLICATION ENTERED | — |